Breast Health

Petal Launches Bra-insert Women’s Health Wearable

Tensive Secures Up to €20M to Develop Breast Reconstruction Implant Alternative

ProvanAI Secures $1.2M to Develop Ovarian Cancer Risk Assessment

GE HealthCare Launches AI-Powered Breast Ultrasound

Astrin Biosciences Study Validates Blood Test For Early-Stage Breast Cancer Detection

FDA Approves Celcuity’s REVTORPYK for HR+/HER2-, PIK3CA Wild-Type Advanced Breast Cancer

Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals

Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial

FDA Approves Pfizer’s IBRANCE for HR+/HER2+ Metastatic Breast Cancer

Quibim Launches AI Tool for Breast Cancer Detection via MRI in Europe and the UK

Spotlight Medical Secures CE Mark for AI Breast Cancer Prognostic Test

Mammogen Raises Up to $30M for RNA Blood Test That Could Reduce Unnecessary Breast Biopsies

OPTIMA Trial Finds Gene Test Can Identify Breast Cancer Patients Who Can Safely Forgo Chemotherapy

FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years

FDA Approves ENHERTU for Early Breast Cancer in Two New Indications

Artera Receives FDA Clearance for AI-Powered Breast Cancer Risk Stratification Tool

FDA Approves VEPPANU, a New Class of Targeted Therapy for Advanced Breast Cancer

ScreenPoint Medical Raises $16M to Scale AI-Powered Breast Cancer Detection Globally

Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal

Manta Cares and Gilead Sciences Announce Collaboration to Support Patients Navigating Metastatic Breast and Lung Cancer

iMerit, Segmed, and Advocate Health Release Open-Source 3D Mammography Dataset for AI Research

ScreenPoint Medical’s Breast AI Reduced Interval Cancers by 12% in Landmark Trial

Labcorp Expands Molecular Residual Disease Testing to Include Breast Cancer Recurrence Monitoring

Biocartis and Mayo Clinic to Collaborate on Rapid Breast Cancer Diagnostic Test